T0	Participants 69 100	growth hormone-deficient women.
T1	Participants 200 224	GH-deficient (GHD) women
T2	Participants 271 311	In two separate studies, eight GHD women
T3	Participants 1396 1405	GHD women
T4	Participants 1482 1491	GHD women